Canaccord Genuity Reiterates a 'Buy' on AngioDynamics (ANGO); Solid F2Q Offset By Recall

January 6, 2012 9:32 AM EST
Get Alerts ANGO Hot Sheet
Price: $15.75 -0.44%

Rating Summary:
    8 Buy, 6 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on AngioDynamics (NASDAQ: ANGO) price target of $18.50.

Canaccord analyst, Jason R. Mills, said, "FQ2 was the second quarter in a row ANGO beat expectations; however, a recall impacted GAAP EPS and resulted in F2012 guidance tightened to the lower end of the previous range. That said, the recall was voluntary and likely immaterial beyond next Q (FQ3), so we view any weakness in ANGO shares as an opportune time to buy the stock."

For an analyst ratings summary and ratings history on AngioDynamics click here. For more ratings news on AngioDynamics click here.

Shares of AngioDynamics closed at $14.63 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments